Skip to main content
Prism Medico and Pharmacy Ltd. logo

Prism Medico and Pharmacy Ltd. — Investor Relations & Filings

Ticker · 512217 ISIN · INE730E01016 BSE.NS Wholesale and retail trade
Open in API
Filings indexed 478 across all filing types
Latest filing 2026-05-23 Regulatory Filings
Country IN India
Listing BSE.NS 512217

About Prism Medico and Pharmacy Ltd.

http://www.prismmedico.in/

Prism Medico and Pharmacy Ltd. is a healthcare-oriented enterprise focused on the trading, distribution, and supply of pharmaceutical products and medical equipment. The company manages a diverse portfolio of medicinal formulations, including generic drugs, branded medications, and surgical supplies. Its core operations involve the procurement of healthcare goods from manufacturers and their subsequent distribution to a network of hospitals, clinics, and retail outlets. By maintaining a robust supply chain infrastructure, the organization ensures the availability of essential therapeutic products across various medical categories. The company prioritizes operational efficiency and quality control in its distribution processes to support the requirements of healthcare providers and patients.

Recent filings

Filing Released Lang Actions
Prism Medico And Pharmacy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 ,inter alia, to consider and approve With reference to ....
Regulatory Filings Classification · 90% confidence The document is an official intimation to stock exchanges under SEBI LODR Regulation 29, notifying a scheduled Board of Directors meeting to approve audited financial results. It is not the financial results themselves, nor a report publication, nor a change in board composition. This is a general regulatory announcement required by listing rules, fitting the fallback category “Regulatory Filings” (RNS).
2026-05-23 English
Dear Sir / Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors ....
Regulatory Filings Classification · 85% confidence The document is a notice to stock exchanges under SEBI LODR Regulation 30 disclosing the outcome of a Board meeting (appointment of internal auditors). It is a compliance/regulatory announcement rather than a full financial report, earnings release, or management discussion. There is no specific category for “Board Meeting Outcome” beyond general regulatory filings. Therefore it falls under the fallback category: Regulatory Filings (RNS).
2026-05-11 English
With reference to the subject cited, this is to inform the Exchange that the meeting of the Board of Directors of Prism Medico and Pharmacy Limited held on Tuesday, May 05, 2026 at the ....
Share Issue/Capital Change Classification · 96% confidence The document is a notification titled “Outcome of Board Meeting” addressed to stock exchanges (BSE and MSEI). It details the Board’s approval of the allotment of new equity shares and convertible warrants on a preferential basis. This constitutes an announcement of a share issuance/capital change rather than a full financial report or regulatory filing for a different purpose. Therefore, it fits the “Share Issue/Capital Change” category (Code: SHA).
2026-05-05 English
With reference to the subject cited, this is to inform the Exchange that the meeting of the Board of Directors of Prism Medico and Pharmacy Limited held on Tuesday, May 05, 2026 at the ....
Share Issue/Capital Change Classification · 90% confidence The document is an official stock exchange filing titled “Outcome of Board Meeting,” detailing the board’s approval of the allotment of 75,00,000 equity shares and 50,00,000 convertible warrants. This is an announcement of new share issues, i.e., a capital change. Per the definitions, announcements of new share issues and capital changes are classified as Share Issue/Capital Change (SHA).
2026-05-05 English
Dear Sir/Madam, Please find the attached confirmation regarding non-applicability of large corporate entity framework. You are requested to take the same on record and oblige. Thanks ....
Regulatory Filings
2026-04-29 English
Dear Sir/Madam, Pursuant to Regulation 13(3) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, please find the attached certificate from the RTA for the ....
Regulatory Filings
2026-04-21 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.